Unknown

Dataset Information

Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy.


ABSTRACT: Anti-angiogenesis therapy and immunotherapy are the first-line therapeutic strategies for various tumor treatments in the clinic, bringing significant advantages for tumor patients. Recent studies have shown that anti-angiogenic therapy can potentiate immunotherapy, with many clinical trials conducted based on the combination of anti-angiogenic agents and immune checkpoint inhibitors (ICIs). However, currently available clinical dosing strategies and tools are limited, emphasizing the need for more improvements. Although significant progress has been achieved, several big questions remained, such as how to achieve cell-specific targeting in the tumor microenvironment? How to improve drug delivery efficiency in tumors? Can nanotechnology be used to potentiate existing clinical drugs and ach

SUBMITTER: Xiao M 

PROVIDER: S-EPMC9745116 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature